Cargando…

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Almost all multiple myeloma (MM) cases have been demonstrated to be linked to earlier monoclonal gammopathy of undetermined significance (MGUS). Nevertheless, there are no identified characteristics in the diagnosis of MGUS that have been helpful in differentiating subjects whose cancer may progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allegra, Alessandro, Innao, Vanessa, Allegra, Andrea Gaetano, Pugliese, Marta, Di Salvo, Eleonora, Ventura-Spagnolo, Elvira, Musolino, Caterina, Gangemi, Sebastiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600674/ https://www.ncbi.nlm.nih.gov/pubmed/31185596 http://dx.doi.org/10.3390/ijms20112822

Ejemplares similares

Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies
por: Innao, Vanessa, et al.
Publicado: (2021)

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
por: Musolino, Caterina, et al.
Publicado: (2017)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
por: Innao, Vanessa, et al.
Publicado: (2021)

Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Damasceno, Daniela, et al.
Publicado: (2021)

New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges
por: Allegra, Alessandro, et al.
Publicado: (2021)

Antiproliferative Effects of St. John’s Wort, Its Derivatives, and Other Hypericum Species in Hematologic Malignancies
por: Allegra, Alessandro, et al.
Publicado: (2020)

Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016)

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020)

New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
por: Innao, Vanessa, et al.
Publicado: (2020)

Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)

Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
por: Aslam, Nabeel, et al.
Publicado: (2021)

Formaldehyde Exposure and Acute Myeloid Leukemia: A Review of the Literature
por: Allegra, Alessandro, et al.
Publicado: (2019)

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021)

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Yu, Pak Lok Ivan, et al.
Publicado: (2019)

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
por: Hannaford, Alisse, et al.
Publicado: (2017)

Network-based analysis of the molecular mechanisms of multiple myeloma and monoclonal gammopathy of undetermined significance
por: Liu, Zhi, et al.
Publicado: (2017)

Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
por: Li, Jia, et al.
Publicado: (2020)

The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma
por: Yi, Zhigang, et al.
Publicado: (2022)

Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
por: Şahver İşgör, İrem, et al.
Publicado: (2022)

It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma
por: Choa, Ruth, et al.
Publicado: (2023)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient
por: Innao, Vanessa, et al.
Publicado: (2017)

Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
por: Allegra, Andrea Gaetano, et al.
Publicado: (2020)

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
por: Innao, Vanessa, et al.
Publicado: (2020)

Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
por: Steiner, Normann, et al.
Publicado: (2016)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2022)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
por: Lyle, Melissa A., et al.
Publicado: (2022)

Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance
por: Yasuyama, Masako, et al.
Publicado: (2012)

Immune Defects in the Risk of Infection and Response to Vaccination in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Tete, Sarah M., et al.
Publicado: (2014)

Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
por: Tomasson, Michael H., et al.
Publicado: (2018)

Relationship between Monoclonal Gammopathy of undetermined significance and multiple myeloma via online database analysis
por: Lu, Weiguo, et al.
Publicado: (2023)

The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients
por: Allegra, Alessandro, et al.
Publicado: (2020)

Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
por: Hartley, M.A., et al.
Publicado: (2010)

Aspergillus fumigatus Scleritis Associated with Monoclonal Gammopathy of Undetermined Significance
por: Jo, Dong Hyun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bqovkg5vh04r6gn8rv4c5aa295